Invivyd Future Growth
Future criteria checks 3/6
Invivyd is forecast to grow earnings and revenue by 65.1% and 40% per annum respectively. EPS is expected to grow by 67.1% per annum. Return on equity is forecast to be 32.3% in 3 years.
Key information
65.1%
Earnings growth rate
67.1%
EPS growth rate
| Biotechs earnings growth | 21.3% |
| Revenue growth rate | 40.0% |
| Future return on equity | 32.3% |
| Analyst coverage | Low |
| Last updated | 08 Apr 2024 |
Recent future growth updates
Recent updates
Is Invivyd (NASDAQ:IVVD) In A Good Position To Invest In Growth?
Mar 29
We're Keeping An Eye On Invivyd's (NASDAQ:IVVD) Cash Burn Rate
Oct 24We're Keeping An Eye On Invivyd's (NASDAQ:IVVD) Cash Burn Rate
Jul 04Will Invivyd (NASDAQ:IVVD) Spend Its Cash Wisely?
Mar 19Is Invivyd (NASDAQ:IVVD) In A Good Position To Deliver On Growth Plans?
Nov 19Invivyd appoints interim CFO, makes headcount changes
Oct 13Adagio Therapeutics changes name to Invivyd, generates COVID-19 antibodies
Sep 12Adagio Therapeutics GAAP EPS of -$0.47
Aug 15We're Keeping An Eye On Adagio Therapeutics' (NASDAQ:ADGI) Cash Burn Rate
Jul 30Adagio names David Hering as permanent CEO and Director
Jul 05Adagio's Round Trip
Mar 02We're Interested To See How Adagio Therapeutics (NASDAQ:ADGI) Uses Its Cash Hoard To Grow
Feb 19Adagio: A COVID-19 Play With Big Potential On Possible Treatment And Prevention
Feb 16Adagio Therapeutics: The Market Is Too Crowded For Its Lead Drug Candidate
Nov 29Earnings and Revenue Growth Forecasts
| Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
|---|---|---|---|---|---|
| 12/31/2026 | 475 | -17 | -19 | -6 | 3 |
| 12/31/2025 | 326 | -61 | -118 | -106 | 4 |
| 12/31/2024 | 176 | -136 | -159 | -148 | 4 |
| 12/31/2023 | N/A | -199 | -174 | -173 | N/A |
| 9/30/2023 | N/A | -170 | -163 | -161 | N/A |
| 6/30/2023 | N/A | -175 | -184 | -182 | N/A |
| 3/31/2023 | N/A | -176 | -204 | -202 | N/A |
| 12/31/2022 | N/A | -241 | -222 | -220 | N/A |
| 9/30/2022 | N/A | -280 | -246 | -246 | N/A |
| 6/30/2022 | N/A | -295 | -244 | -244 | N/A |
| 3/31/2022 | N/A | -289 | -220 | -220 | N/A |
| 12/31/2021 | N/A | -227 | -185 | -185 | N/A |
| 9/30/2021 | N/A | -208 | -135 | -135 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: IVVD is forecast to remain unprofitable over the next 3 years.
Earnings vs Market: IVVD is forecast to remain unprofitable over the next 3 years.
High Growth Earnings: IVVD is forecast to remain unprofitable over the next 3 years.
Revenue vs Market: IVVD's revenue (40% per year) is forecast to grow faster than the US market (8% per year).
High Growth Revenue: IVVD's revenue (40% per year) is forecast to grow faster than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: IVVD's Return on Equity is forecast to be high in 3 years time (32.3%)